从 COVID-19 大流行中我们所学到的：是时候跳出固有思维了，也许要远远地跳出去。
What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside.
机构信息
Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA; Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
出版信息
Clin Dermatol. 2021 Jan-Feb;39(1):107-117. doi: 10.1016/j.clindermatol.2020.12.020. Epub 2020 Dec 16.
Abstract
The coronavirus disease 2019 pandemic has had a profound effect on our lives and careers; this presentation explores some of the lessons we have learned from it and others that it may yet teach us. Socioeconomic effects have been profound, not all of them favorable. Travel and meeting activities, as well as many other activities, have been severely restricted. Social unrest has become intense, and it may have questionable political consequences, as the United States is undergoing a contested election result.
摘要
2019 年冠状病毒病大流行对我们的生活和职业产生了深远的影响；本演讲探讨了我们从中吸取的一些教训，以及它可能还会教给我们的其他教训。社会经济影响是深远的，并非所有影响都是有利的。旅行和会议活动以及许多其他活动受到严重限制。社会动荡加剧，可能产生有问题的政治后果，因为美国正在经历有争议的选举结果。
相似文献
1
What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside.从 COVID-19 大流行中我们所学到的：是时候跳出固有思维了，也许要远远地跳出去。
Clin Dermatol. 2021 Jan-Feb;39(1):107-117. doi: 10.1016/j.clindermatol.2020.12.020. Epub 2020 Dec 16.
2
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.在大流行期间启动的 2019 年冠状病毒病随机临床试验的多发性特征。
JAMA Netw Open. 2020 Jul 1;3(7):e2015100. doi: 10.1001/jamanetworkopen.2020.15100.
3
Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.低负担地区住院 COVID-19 患者的临床特征和结局。
Pathog Glob Health. 2021 Jun;115(4):243-249. doi: 10.1080/20477724.2021.1893485. Epub 2021 Feb 28.
4
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.疫情期间加利福尼亚州新冠肺炎住院患者的用药模式
JAMA Netw Open. 2021 May 3;4(5):e2110775. doi: 10.1001/jamanetworkopen.2021.10775.
5
Repurposing antimalarials and other drugs for COVID-19.将抗疟药及其他药物重新用于治疗新冠肺炎。
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
6
Audio Interview: Studying Potential Covid-19 Therapies.音频访谈：研究潜在的新冠病毒治疗方法。
N Engl J Med. 2020 May 7;382(19):e72. doi: 10.1056/NEJMe2015955.
7
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
8
Possible treatment and strategies for COVID-19: review and assessment.针对 COVID-19 的可能治疗方法和策略：综述与评估。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12593-12608. doi: 10.26355/eurrev_202012_24057.
9
COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.新型冠状病毒疾病药物氯喹和羟氯喹，但不是阿奇霉素和瑞德西韦，可阻断 hERG 钾通道。
J Pharmacol Exp Ther. 2021 May;377(2):265-272. doi: 10.1124/jpet.120.000484. Epub 2021 Mar 5.
10
Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.新冠肺炎住院患者中的肺炎链球菌合并感染
Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1353-1355. doi: 10.1007/s10096-021-04166-w. Epub 2021 Jan 19.
引用本文的文献
1
Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.新冠后神经精神表现：阿奇霉素治疗“长新冠”的建议方法。
Epidemiol Infect. 2023 Dec 15;152:e34. doi: 10.1017/S0950268823001966.
本文引用的文献
1
COVID-19-specific skin changes related to SARS-CoV-2: Visualizing a monumental public health challenge.与 SARS-CoV-2 相关的 COVID-19 特异性皮肤改变：凸显一项重大的公共卫生挑战。
Clin Dermatol. 2021 May-Jun;39(3):374-379. doi: 10.1016/j.clindermatol.2021.01.009. Epub 2021 Feb 1.
2
Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.广义脓疱状匐行性红斑：两例服用羟氯喹的COVID-19患者的首例报告
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e5-e7. doi: 10.1111/jdv.16903. Epub 2020 Sep 17.
3
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.概述：由 SARS-CoV-2 感染引起的肺损伤导致的全身炎症反应解释了 COVID-19 的严重结局。
Front Immunol. 2020 Jun 26;11:1626. doi: 10.3389/fimmu.2020.01626. eCollection 2020.
4
Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19.弥散性血管内凝血：一种特别与 COVID-19 相关的致命性全身性疾病。
Dermatol Ther. 2020 Nov;33(6):e14053. doi: 10.1111/dth.14053. Epub 2020 Sep 4.
5
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.住院的新冠肺炎患者与静脉血栓栓塞：一场完美风暴。
Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.
6
Covid-19 treatment-induced neuropsychiatric adverse effects.新冠病毒病治疗引起的神经精神不良反应。
Gen Hosp Psychiatry. 2020 Nov-Dec;67:163-164. doi: 10.1016/j.genhosppsych.2020.06.001. Epub 2020 Jun 10.
7
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.羟氯喹、阿奇霉素和联合治疗 COVID-19 住院患者。
Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2.
8
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.新型冠状病毒感染的皮肤表现：临床最新进展。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2499-2504. doi: 10.1111/jdv.16774. Epub 2020 Jul 20.
9
Convalescent plasma and COVID-19 treatment.恢复期血浆与新冠病毒病治疗
Minerva Med. 2023 Oct;114(5):738-739. doi: 10.23736/S0026-4806.20.06670-7. Epub 2020 Jun 12.
10
Early safety indicators of COVID-19 convalescent plasma in 5000 patients.5000 例 COVID-19 恢复期血浆治疗的早期安全性指标。
J Clin Invest. 2020 Sep 1;130(9):4791-4797. doi: 10.1172/JCI140200.
Zotero 插件